/ /

LATEST

Global perspecitves on cosmetic fillersWith so many new and exciting filler products in the U.S. pipeline, American dermatologists and their patients are in for a treat, according to Hassan I. Galadari, M.D.
Center’s goal: Give skin disease researchers all they needA new research center makes a database of five million human pathology specimens and 22,000 living consented patients, all searchable by diagnoses, as well as cutting edge human analytic techniques available to anyone interested in carrying out translational skin disease research on human cells and tissues.
Research gaps persist in psoriasis, psoriatic arthritisBeing able to predict which patients will respond to which treatments will help dermatologists in treating psoriasis, preventing progression to psoriatic arthritis and reducing comorbidities.
PDT addresses '50 shades of solar damage'PDT is underutilized as field treatment for AKs. An expert pushes for two to three hours' incubation time in her clinic and suggests efficacy-elevating pretreatment of lesions.
6 considerations before making that laser purchaseChoosing the right laser devices can add to the bottom line and patient satisfaction; choosing the wrong devices can be a drain on a practice’s viability.
Emerging cosmeceuticalsWhile there is still much to learn about these new products, preliminary studies are promising, according to Patricia Farris, M.D.
5 tips to enhance the surgical experienceDrs. Charlene Lam and Elizabeth Billingsley offer insights to optimize the surgical experience for dermatologists and their patients.
Apps distract patients from procedure painTaking the sting and stress out of dermatologic procedures requires low-tech distraction techniques and, often in the case of children, amusing apps.
Flexibility guides EHR futureCMS' meaningful use program for electronic health records (EHRs) has morphed into the Advancing Care Information (ACI) initiative, which loosens restrictions for earning EHR bonuses.
A new era in atopic derm treatment
A new era in atopic derm treatmentPromising new treatments recently approved or under development for atopic dermatitis include crisaborole, JAK inhibitors and dupilumab, an expert said.

Poll

View Results